WebJul 15, 2024 · In furtherance of President Biden’s Cancer Moonshot initiative, the White House recently announced the United States Patent and Trademark Office’s (USPTO) recent renewal of our Cancer Immunotherapy Pilot Program. This program provides a fast-track review for cancer immunotherapy-related patent applications without the … WebSep 22, 2024 · In June 2024, we wrote about the United States Patent and Trademark Office (USPTO) extending the Cancer Immunotherapy Pilot Program (also known as “Patents 4 Patients”) until December 31, 2024. (here). Applications that qualify for the program are given “special” status with the USPTO and are fast tracked through …
Patents 4 Patients USPTO
WebFeb 27, 2024 · The new program replaces the Cancer Immunotherapy Pilot Program, which expedited examination for eligible patent applications pertaining to methods of treating cancer using immunotherapy. The new program is open to a broader range of patent applications, including those directed to other treatment modalities and some cancer … WebThe Pilot Program, which accelerates the examination of patent applications directed to cancer immunotherapy methods, will now expire on December 31, 2024, absent further extension. The PTO implemented the Pilot Program a year ago as part of the National Cancer Moonshot initiative. chester county pa historical society
Targeting advanced prostate cancer with STEAP1 chimeric antigen ...
WebOct 3, 2024 · The Cancer Immunotherapy Pilot Program (also referred to as the Patents 4 Patients program) has been extend through January 31, 2024. This program is … WebJan 18, 2024 · The Moonshot Program replaces and expands the current “Cancer Immunotherapy Pilot Program” (also called “Patents for Patients” or “P4P”). The Moonshot Program is scheduled to continue until the earlier of January 31, 2025 or until the USPTO has accepted 1,000 grantable petitions. WebJun 28, 2024 · On June 19, 2024, the U.S. Patent and Trademark Office (USPTO) announced that it would be extending the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immun chester county pa homeless services